ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Jeff, you are correct Simes was CEO of Unimed and got Phase 3 Androgel trials started before being lured away by Dr Louis W. Sullivan to be CEO of Biosante. Unimed was then acquired by Solvay which was acquired by Abbott and eventually became part of Abbvie when it was spun off from Abbott Labs.

I see ANIP and possibly Endo addressing a bigger issue for Abbvie.

J&J,Pfizer,Merck, Novartis and Amgen from a Market Cap perspective are all above Abbvie on the food chain. They are all in the biosimilar game. Unless Abbvie is to be acquired, they will most likely need to get into biosimilars.

I see Anip being acquired by Abbvie for Libigel and it eventually becomes the Generics/Biosimilar Division of Abbvie. Similar to Sandoz relationship with Novartis.

Libigel will offset Humira sales decline. But I don't think they can, or will ignore the biosimilar market.

Seeing the cards presently on the table, this is how I would play it with the cards that have been dealt.